Semaglutide injection products, primarily branded as Ozempic and Wegovy, are GLP-1 receptor agonists designed for weekly, subcutaneous, self-administered weight management and type 2 diabetes treatment. These products are typically indicated for chronic weight management alongside lifestyle changes, or glycemic control in adults.